Kristoffer Staal Rohrberg

机构：University of Copenhagen, Copenhagen University Hospital, Rigshospitalet · ORCID：0000-0002-5448-9003

发表论文 236 篇 · 总被引 2598 次 · h-index 20

代表论文

Rilvegostomig for Metastatic Non–Small Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study (2026 · Clinical Cancer Research · 被引 1)
Table 2 from A Phase Ib/II Study of Atezolizumab in Combination with Thiopurine Therapy in Patients with Metastatic Solid Tumors and Intermediate Tumor Mutational Burden (2026)
Figure 2 from A Phase Ib/II Study of Atezolizumab in Combination with Thiopurine Therapy in Patients with Metastatic Solid Tumors and Intermediate Tumor Mutational Burden (2026)
Supplementary Table S4 from A Phase Ib/II Study of Atezolizumab in Combination with Thiopurine Therapy in Patients with Metastatic Solid Tumors and Intermediate Tumor Mutational Burden (2026)
Supplementary Figure S1 from A Phase Ib/II Study of Atezolizumab in Combination with Thiopurine Therapy in Patients with Metastatic Solid Tumors and Intermediate Tumor Mutational Burden (2026)
Data from A Phase Ib/II Study of Atezolizumab in Combination with Thiopurine Therapy in Patients with Metastatic Solid Tumors and Intermediate Tumor Mutational Burden (2026)